What is the recommended non‑operative medical management for an adult patient with subacute (early or chronic) appendicitis presenting with stable vital signs, localized right lower quadrant pain, no signs of perforation, peritonitis, or abscess, and imaging confirming the diagnosis?

Medical Management of Subacute Appendicitis

For an adult patient with subacute appendicitis presenting with stable vital signs and no signs of perforation, peritonitis, or abscess, non-operative management with broad-spectrum antibiotics is a safe and effective treatment option that can successfully resolve symptoms in approximately 90% of cases. 1, 2

Treatment Approach

Initial Antibiotic Therapy

The cornerstone of medical management is broad-spectrum antibiotic therapy. Based on the 2020 WSES Jerusalem Guidelines, you should initiate antibiotics that cover both aerobic and anaerobic organisms 1. The typical regimen involves:

• Intravenous antibiotics initially, followed by transition to oral antibiotics once clinical improvement is demonstrated
• Duration: Treatment courses typically range from 3-5 days for adequate source control 1
• Common regimens include combinations covering gram-negative and anaerobic bacteria (e.g., fluoroquinolone or third-generation cephalosporin plus metronidazole, or piperacillin-tazobactam)

Expected Outcomes and Monitoring

Success rates are high: Recent prospective data shows 90% complete symptom resolution with antibiotic therapy alone 2. However, you must counsel patients about the 12-24% recurrence risk over the following year 1.

Monitor for:

• Resolution of right lower quadrant pain
• Normalization of fever and inflammatory markers
• Absence of peritoneal signs
• Ability to tolerate oral intake

Critical Predictors of Treatment Failure

The presence of an appendicolith is the most important predictor of antibiotic treatment failure 3. Other factors associated with failure include:

• Persistent fever despite antibiotics
• Elevated inflammatory markers (WBC, CRP)
• Increased appendiceal diameter on imaging (>10-11mm)
• Development of peritoneal signs

If any of these features are present or develop during treatment, surgical consultation should be obtained promptly.

Age-Specific Considerations

Patients ≥40 Years Old

This is a critical caveat: For patients 40 years or older treated non-operatively, the incidence of underlying appendiceal neoplasms is unexpectedly high at 3-17% 1.

You must arrange follow-up imaging and colonoscopy 1:

• Interval contrast-enhanced CT scan
• Colonoscopy for colonic screening
• These should be performed after resolution of acute inflammation

This recommendation stems from a prematurely terminated RCT that found a 17% rate of neoplasms in patients over 40 treated conservatively, with all neoplasms occurring in this age group 1.

Patients <40 Years Old

For younger adults and children, routine interval appendectomy is not recommended after successful non-operative management 1. Surgery should be reserved only for those who develop recurrent symptoms.

When Surgery Becomes Necessary

Approximately 10% of patients will require surgical intervention due to disease progression during initial antibiotic treatment 2. Indications for conversion to surgery include:

• Failure to improve within 24-48 hours of antibiotic therapy
• Development of peritonitis or sepsis
• Formation of abscess (though percutaneous drainage may be an option)
• Patient preference after shared decision-making
• Recurrent episodes of appendicitis

Practical Algorithm

1. Confirm diagnosis: Imaging-confirmed uncomplicated appendicitis without abscess, perforation, or peritonitis
2. Check age: If ≥40 years, counsel about mandatory follow-up imaging and colonoscopy
3. Assess for appendicolith: If present on imaging, strongly consider surgery as first-line due to high failure rates
4. Initiate IV broad-spectrum antibiotics covering gram-negative and anaerobic organisms
5. Monitor closely for 24-48 hours: Clinical improvement should be evident
6. Transition to oral antibiotics once improving, complete 3-5 day course
7. Counsel about 12-24% recurrence risk over the next year
8. Arrange follow-up: Especially critical for patients ≥40 years (CT and colonoscopy)

Comparative Context

While the 2025 WSES guidelines 4 and recent reviews 5, 6, 3 continue to support non-operative management as safe and effective, laparoscopic appendectomy remains the definitive treatment with minimal recurrence risk 3. The choice between medical and surgical management should involve shared decision-making, weighing the patient's preference to avoid surgery against the 12-24% chance of recurrence and need for eventual appendectomy in some cases.

The key advantage of antibiotics is avoiding surgical risks; the key disadvantage is the substantial recurrence rate requiring either repeat antibiotics or eventual surgery anyway 1, 2.